Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
European health officials have advocated portfolio diversity to help fight different variants
More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out
Novavax had a terrible week while Pfizer and Moderna are well off their pandemic highs
Manufacturing woes meant it lost out in race to market with its Covid vaccine
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
Bargain-hunters enter market after sell-off on economic worries
Pyongyang says it has kept its population Covid-free by sealing the country’s borders
Three doses can protect against serious illness and death for a long time, studies suggest
‘I was called an anti-vaxxer, and I took exception to that. My children are vaccinated’
Investors’ appetites for risk increases as fears recede over economic impact of Omicron
Validity will be extended after booster shot without a time limit
Total global output will be more than 20 billion shots for the year
Moderna will be the main vaccine administered over coming weeks to over-60s, over-50s, healthcare workers and younger people in vulnerable groups
‘It was like a tap being turned on from Thursday or Friday last week. It’s been mostly young people’
Johnson unveils ‘temporary and precautionary’ Covid restrictions to slow variant
Tablet has potential to avoid nine of 10 hospitalisations with virus, says pharma giant
Company to submit application for US authorisation by end of the year
Company has filed for regulatory authorisation for shot in India, Indonesia, Philippines
World wrap: Sydney lockdown could last months as daily cases reach record high
US vaccination take-up rates are slowing, as Novavax jab on course for autumn approval
CEO expects early supplies to be used for Covax supplies as analysts eye shot as booster option
Company is talking to governments about creating vaccine manufacturing facilities
Vaccine-makers drop on Wall Street after Biden backs intellectual property waivers
Ireland is in line for up to 2.2m doses of company’s vaccine supply from late-2021
Explainer: The best vaccine is the one that you are offered, say public-health doctors
Oxford scientists test vaccine combinations amid concern over rare side effects
Serum institute is biggest supplier to the international Covax programme
Firm facing complaints over delivery pledges but also reports of possible side effects
EU hoping to buy up to 200m Novavax vaccines
Company to deliver 200m doses to EU with 600,000 to Republic between April and June
EU has deal with company for millions of doses
Daily updates as Ireland embarks on largest inoculation programme in its history
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices